The Clinical Immunotherapy subcommittee has been active in conducting discussions on barriers to product development and making recommendations for their resolution, sponsoring lectures to enhance the knowledge base of intramural investigators in translational medicine and regulatory issues, identifying opportunities to work with existing programs in the intramural and extramural programs, and building collaborations and utilizing contractors to assist in product development and regulatory issues. Through these efforts, this subcommittee contributes to the goal of reducing the burden of cancer.

The Clinical Immunotherapy subcommittee also promotes communication among its members and with the NIH research community by sponsoring seminars and discussion sessions at which current topics of interest are discussed and future directions are planned. The seminar series has fostered communication among members of the Immunology Center of Excellence and affords continued information exchange as well as critical review of individual research efforts.

In 2003, the subcommittee sponsored several seminars. Dr. Kathryn Zoon presented a discussion of the regulation and approval of drug and biological drug products. Dr. Ed Sausville presented a seminar on the NCI's Drug Therapeutics Program in areas including toxicology testing and product manufacturing and testing (Biopharmaceutical Development Program).